Dipjyoti Das

About Dipjyoti Das

Duke Fuqua MBA \'26 · Physician-executive with 15+ years in healthcare — 5 years clinical medicine, 10+ years in management and strategy across India, Bangladesh, and the US. Reached 55M+ patients, influenced $500M+ in government health financing, and procured $200M+ in capital instruments as the actual clinical buyer — not an advisor. Published in The Lancet Oncology. Government of India recognition (2024).FOCUS: Pharma | Med Device & MedTech | Healthcare Operations | Startups & HealthTech | Consulting MED DEVICE & MEDTECHBuyer of $200M+ in instruments — LINACs, MRI/CT, Da Vinci robots, proton therapy, flow cytometry — across 17+ hospitals. Full lifecycle: vendor selection to LIS/LIMS integration, QC validation, HCP training. Planned NE India\'s first proton therapy centre. Commissioned Bangladesh\'s largest hospital $12M under budget, 3 months early. IIT Guwahati AI collaboration. Now at MGH via Fuqua FCCP. HEALTHCARE OPERATIONSBuilt South Asia\'s largest oncology programme — 17 hospitals, 55M+ patients — Government of India national benchmark (2024). Medical Director & COO, Apollo: 65% revenue growth,#2 national ranking, 22% volume growth. Fortis: West India\'s first heart transplant green corridor — 75% reduction in critical transport time. PHARMAFormulary decision-maker across 17 hospital accounts. Pharma partnerships with Pfizer and MSD — patient programmes, oncology protocols, generic injectables. HEOR and CAR-T budget impact models (ASP+, DRG) at Duke/Med1Ventures. Chaired NEOS CME three consecutive years — physicians trained. World Cancer Congress, Geneva (2023). STARTUPS & HEALTHTECHAdvised MedTech startups via Guidepoint on GTM, regulatory pathways, and commercial positioning. Deployed NAVYA AI and Qure.ai across 17 sites — 20% referral accuracy improvement, 18% patient leakage reduction. Demand planning models at Duke/Med1Ventures influenced a $20M spinoff decision.🤝 CONSULTINGGTM strategy for two MGH radiology innovations (Fuqua FCCP).$120M pharma and device market re-entry advisory across 3 Asian geographies. Duke Fuqua Merit Scholar — LBO modelling, Medical Device Strategy, Health Sector Management.Recognition: Govt. of India (2024) · Youngest member, India\'s National DNB Committee · TISS Gold Medallist MHA · Fortis Employee of the Year (2017) · Navbharat Times Award (2018)Publications: 10+ peer-reviewed papersEducation: Duke Fuqua MBA \'26 · IIM Ahmedabad MMS · MBBS, Gauhati Medical CollegeGraduating May 2026. Open to connecting, sharing insights, or exploring how I can add value to your team.

Experience

1. Consultant Pm-fccp

   Massachusetts General Hospital

   Dec 2025 — Present · Durham, NC, US

   Developing go-to-market strategy and commercial readiness roadmap for 2 MGH radiology diagnostic innovations; conducting market research and customer insights analysis to define competitive positioning. Mapping physician adoption drivers across clinical laboratory and reference lab settings; building customer engagement and field enablement framework for product launch.

Education

• Indian Institute of Management Ahmedabad

  MMS, Business Administration and Management, General

  2019 — 2021

• Guwahat govenment medical college,Assam,India

  Bachelor of Medicine, Bachelor of Surgery (MBBS) equivalent to MD in USA, MBBS

• Kendriya Vidyalaya

  High School, maths,biology,phy,chem,english

• Duke University - The Fuqua School of Business

  Master of Business Administration - MBA

  2026

• Tata Institute of Social Sciences

  Master’s Degree, Hospital administration(full time)